Nrx Pharmaceuticals Inc (NRXP)

$2.98 +0.07 (2.41%)
Market Cap 96.23M
Revenue (ttm) 1.23M
Net Income (ttm) -28.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 22.69
Profit Margin -2,326.83%
Debt to Equity Ratio 0.00
Volume 958,900
Avg Vol 907,018
Day's Range N/A - N/A
Shares Out 33.07M
Stochastic %K 58%
Beta 1.83
Analysts Strong Sell
Price Target $38.25

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology
Sector: Healthcare
Phone: 484 254 6134
Address:
1201 Orange Street, Suite 600, Wilmington, United States
FounderV
FounderV May. 1 at 2:28 AM
$NRXP I wish Lucky Friday...
0 · Reply
jonny80s
jonny80s Apr. 30 at 3:58 PM
$NRXP 7-10 days before the push begins for the Q1 release. Hold in there folks.
0 · Reply
dontfeedthebashers
dontfeedthebashers Apr. 30 at 2:24 PM
$SCHD $FDVV $NRXP 65%/25%/10%
1 · Reply
Outcomes
Outcomes Apr. 30 at 11:22 AM
$IBRX $NRXP .....'Makary also mentioned a new AI tool that the agency will start using "very soon" that he says will shave 2 months off decision time for all drug reviews. He also touted his Commissioner's National Priority Voucheropens in a new tab or window program that has resultedopens in a new tab or window in seven decisionsopens in a new tab or window, with another 21 products selected for such review, including three psychedelic compoundsopens in a new tab or window announced last week.' https://www.medpagetoday.com/washington-watch/fdageneral/121006
0 · Reply
Outcomes
Outcomes Apr. 30 at 10:59 AM
$NRXP https://mindmazetherapeutics.com/mindmaze-therapeutics-and-vibra-healthcare-announce-go-to-market-partnership-to-expand-commercial-footprint-of-precision-neurotherapeutics-in-the-u-s/
1 · Reply
nick_m
nick_m Apr. 29 at 8:30 PM
$NRXP loaded zone IMO 🚀🚀🚀
0 · Reply
jonny80s
jonny80s Apr. 29 at 5:23 PM
$NRXP apparently it does take a month or 3, or more…. it’s not like Javitt hasn’t been off by years on this NDA submission before???? December 2024, 16 months and counting.
3 · Reply
tootlicket
tootlicket Apr. 29 at 4:46 PM
$NRXP Dude, you talk about so much shit and your posts are all over the place. You get one like per post. So many predictions?? Everyone knows this ticker sux save yourself all the hassle daily. If you got like 10 likes like David I could see it but damn. You have your opinion but damn, warning new investors? Don't think it's working but party on dude.
1 · Reply
jonny80s
jonny80s Apr. 29 at 3:04 PM
$NRXP uocoming catalysts: -May 18-29th,Q1 report -By June, NRX-100 NDA Submission -By Q2/June, 3 more Hope clinics -July 29th FDA GDUFA -Sept 15-25th 3yr realtime stability results on NRX-100 Loaned out shares are returning at pretty quick pace, my guess is this current pump is about to turn into a dump. Good luck everyone.
1 · Reply
FounderV
FounderV Apr. 29 at 2:00 AM
$NRXP We are the future...
0 · Reply
Latest News on NRXP
NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program

Apr 22, 2026, 7:00 AM EDT - 8 days ago

NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

Apr 20, 2026, 7:00 AM EDT - 10 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications

Apr 15, 2026, 7:00 AM EDT - 15 days ago

NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

Apr 13, 2026, 7:00 AM EDT - 17 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application

Apr 6, 2026, 7:00 AM EDT - 24 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application

Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network

Mar 30, 2026, 7:00 AM EDT - 4 weeks ago

Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network

NRx Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 24, 2026, 8:00 AM EDT - 5 weeks ago

NRx Pharmaceuticals Earnings Call Transcript: Q4 2025

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

Mar 24, 2026, 7:00 AM EDT - 5 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

NRx Pharmaceuticals Transcript: AGM 2026

Mar 23, 2026, 10:00 AM EDT - 5 weeks ago

NRx Pharmaceuticals Transcript: AGM 2026

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

Mar 19, 2026, 7:00 AM EDT - 6 weeks ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx's Preservative-Free Ketamine Application

Mar 17, 2026, 7:00 AM EDT - 6 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx's Preservative-Free Ketamine Application

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Mar 16, 2026, 7:00 AM EDT - 6 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

Mar 9, 2026, 7:00 AM EDT - 7 weeks ago

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Mar 2, 2026, 7:00 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Feb 17, 2026, 7:00 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

Jan 16, 2026, 7:03 AM EST - 3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Jan 14, 2026, 7:03 AM EST - 3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

Jan 5, 2026, 6:57 AM EST - 4 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

Dec 18, 2025, 7:05 AM EST - 4 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

Dec 3, 2025, 7:00 AM EST - 5 months ago

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

NRx Pharmaceuticals Transcript: Study Update

Dec 2, 2025, 9:00 AM EST - 5 months ago

NRx Pharmaceuticals Transcript: Study Update

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

Dec 2, 2025, 8:30 AM EST - 5 months ago

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

Dec 2, 2025, 7:30 AM EST - 5 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

Dec 1, 2025, 8:03 AM EST - 5 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

NRx Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 17, 2025, 8:30 AM EST - 5 months ago

NRx Pharmaceuticals Earnings Call Transcript: Q3 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 17, 2025, 8:03 AM EST - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

Nov 12, 2025, 8:31 AM EST - 6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

Nov 10, 2025, 8:03 AM EST - 6 months ago

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Oct 20, 2025, 8:03 AM EDT - 6 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

NRx Pharmaceuticals Transcript: Noble Capital Markets Emerging Growth Virtual Investor Conference

Oct 8, 2025, 9:30 AM EDT - 7 months ago

NRx Pharmaceuticals Transcript: Noble Capital Markets Emerging Growth Virtual Investor Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

Oct 6, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

Sep 29, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

Sep 24, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

NRx Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 4:30 PM EDT - 8 months ago

NRx Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Sep 8, 2025, 8:17 AM EDT - 8 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

Sep 3, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

Sep 2, 2025, 1:19 PM EDT - 8 months ago

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

Sep 2, 2025, 8:41 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

Aug 27, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

NRx Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 20, 2025, 8:00 AM EDT - 9 months ago

NRx Pharmaceuticals Earnings Call Transcript: Q2 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 18, 2025, 8:10 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Aug 13, 2025, 6:06 PM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

Aug 11, 2025, 4:05 PM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

Aug 11, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

Aug 8, 2025, 8:03 AM EDT - 9 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

Aug 4, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

Jul 29, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

Jun 26, 2025, 8:03 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

Jun 23, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

Jun 16, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 12, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

Jun 5, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

NRx Pharmaceuticals Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

NRx Pharmaceuticals Earnings Call Transcript: Q1 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 15, 2025, 4:03 PM EDT - 1 year ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

May 15, 2025, 10:15 AM EDT - 1 year ago

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

May 13, 2025, 8:03 AM EDT - 1 year ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

May 12, 2025, 8:03 AM EDT - 1 year ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

May 6, 2025, 8:03 AM EDT - 1 year ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

NRx Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 17, 2025, 8:30 AM EDT - 1 year ago

NRx Pharmaceuticals Earnings Call Transcript: Q4 2024

NRx Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 18, 2024, 4:30 PM EST - 1 year ago

NRx Pharmaceuticals Earnings Call Transcript: Q3 2024

NRx Pharmaceuticals Transcript: ThinkEquity Conference 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

NRx Pharmaceuticals Transcript: ThinkEquity Conference 2024

NRx Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

NRx Pharmaceuticals Earnings Call Transcript: Q2 2024

NRx Pharmaceuticals Transcript: H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 27, 2024, 7:00 AM EDT - 2 years ago

NRx Pharmaceuticals Transcript: H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

NRx Pharmaceuticals Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

NRx Pharmaceuticals Earnings Call Transcript: Q1 2024

NRx Pharmaceuticals Earnings Call Transcript: Q4 2023

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NRx Pharmaceuticals Earnings Call Transcript: Q4 2023

NRx Pharmaceuticals Transcript: EGM 2024

Mar 21, 2024, 11:00 AM EDT - 2 years ago

NRx Pharmaceuticals Transcript: EGM 2024

NRx Pharmaceuticals Earnings Call Transcript: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

NRx Pharmaceuticals Earnings Call Transcript: Q3 2023

NRx Pharmaceuticals Earnings Call Transcript: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 2 years ago

NRx Pharmaceuticals Earnings Call Transcript: Q2 2023

NRx Pharmaceuticals Earnings Call Transcript: Q1 2023

May 16, 2023, 8:30 AM EDT - 3 years ago

NRx Pharmaceuticals Earnings Call Transcript: Q1 2023

NRx Pharmaceuticals Earnings Call Transcript: Q4 2022

Mar 30, 2023, 4:30 PM EDT - 3 years ago

NRx Pharmaceuticals Earnings Call Transcript: Q4 2022

FounderV
FounderV May. 1 at 2:28 AM
$NRXP I wish Lucky Friday...
0 · Reply
jonny80s
jonny80s Apr. 30 at 3:58 PM
$NRXP 7-10 days before the push begins for the Q1 release. Hold in there folks.
0 · Reply
dontfeedthebashers
dontfeedthebashers Apr. 30 at 2:24 PM
$SCHD $FDVV $NRXP 65%/25%/10%
1 · Reply
Outcomes
Outcomes Apr. 30 at 11:22 AM
$IBRX $NRXP .....'Makary also mentioned a new AI tool that the agency will start using "very soon" that he says will shave 2 months off decision time for all drug reviews. He also touted his Commissioner's National Priority Voucheropens in a new tab or window program that has resultedopens in a new tab or window in seven decisionsopens in a new tab or window, with another 21 products selected for such review, including three psychedelic compoundsopens in a new tab or window announced last week.' https://www.medpagetoday.com/washington-watch/fdageneral/121006
0 · Reply
Outcomes
Outcomes Apr. 30 at 10:59 AM
$NRXP https://mindmazetherapeutics.com/mindmaze-therapeutics-and-vibra-healthcare-announce-go-to-market-partnership-to-expand-commercial-footprint-of-precision-neurotherapeutics-in-the-u-s/
1 · Reply
nick_m
nick_m Apr. 29 at 8:30 PM
$NRXP loaded zone IMO 🚀🚀🚀
0 · Reply
jonny80s
jonny80s Apr. 29 at 5:23 PM
$NRXP apparently it does take a month or 3, or more…. it’s not like Javitt hasn’t been off by years on this NDA submission before???? December 2024, 16 months and counting.
3 · Reply
tootlicket
tootlicket Apr. 29 at 4:46 PM
$NRXP Dude, you talk about so much shit and your posts are all over the place. You get one like per post. So many predictions?? Everyone knows this ticker sux save yourself all the hassle daily. If you got like 10 likes like David I could see it but damn. You have your opinion but damn, warning new investors? Don't think it's working but party on dude.
1 · Reply
jonny80s
jonny80s Apr. 29 at 3:04 PM
$NRXP uocoming catalysts: -May 18-29th,Q1 report -By June, NRX-100 NDA Submission -By Q2/June, 3 more Hope clinics -July 29th FDA GDUFA -Sept 15-25th 3yr realtime stability results on NRX-100 Loaned out shares are returning at pretty quick pace, my guess is this current pump is about to turn into a dump. Good luck everyone.
1 · Reply
FounderV
FounderV Apr. 29 at 2:00 AM
$NRXP We are the future...
0 · Reply
jonny80s
jonny80s Apr. 28 at 4:04 PM
$NRXP just imagine 1.97million warrants/shares being bought for $226.5m. With the right kind of news it could happen. At only 6.25% dilution. Unfortunately it doesn’t look as though that kind of news is heading our way any time soon.
1 · Reply
DavidBG
DavidBG Apr. 28 at 11:09 AM
$NRXP Yesterday the shorts attempted, with 74.23%-short high trading volume (fintel.io/ss/us/nrxp), to keep NRXP from closing back above the psychologically important $3.00 level, a battle that continued to rage in the minutes before the closing bell. They failed.
1 · Reply
TravisBking87
TravisBking87 Apr. 28 at 2:29 AM
$NRXP Nice call!
0 · Reply
jacksparo
jacksparo Apr. 27 at 10:52 PM
$NRXP I still have faith in this company will see what will happen this summer!
0 · Reply
RocroBio
RocroBio Apr. 27 at 7:02 PM
$NRXP
0 · Reply
BlazingStocks
BlazingStocks Apr. 27 at 6:30 PM
$NRXP - NRx has received a positive review letter (Discipline Review Letter) addressing Drug Quality requesting only “Minor” administrative changes https://finance.yahoo.com/sectors/healthcare/articles/nrx-pharmaceuticals-reports-positive-fda-110000072.html
0 · Reply
flybyme
flybyme Apr. 27 at 3:57 PM
$NRXP So NRXPW warrants are finished the 24.5.2026. Worthlesss. Based on SEC filings from January 2026, the public warrants for NRx Pharmaceuticals, Inc. (NRXPW) have an exercise price of $115.00 per share.
3 · Reply
Trending__Now
Trending__Now Apr. 27 at 3:10 PM
$NRXP An observation. The Canadian breadbasket got hit with several days of a late snowfall. Super el Nina. This means late seeding of crops which increases risk of frost before harvest. With the added cost of fuel, most likely failed crops coming, we're in for much higher food costs this coming year. Those who are into crop futures, such as Cargill, will be all over this. They have their own satellites and decades of data. I wonder who's behind the seeding the sky with chemtrails? There are wicked people out there. Take care. Much higher food costs coming.
1 · Reply
BlazingStocks
BlazingStocks Apr. 27 at 2:01 PM
$NRXP News April 21, 2026 NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program https://finance.yahoo.com/sectors/healthcare/articles/nrx-pharmaceuticals-reports-positive-fda-110000072.html
0 · Reply
jacksparo
jacksparo Apr. 27 at 2:01 PM
$SLS $NRXP $OCGN $HUMA The week starts here in a positive note but the closing price will be the important piece of the puzzle for the day! I am sharing my continuous non stop live updates in my Live Telegram biotech group 📈✅📈✅!
1 · Reply
jonny80s
jonny80s Apr. 27 at 1:06 PM
$NRXP has anyone watched New to the Streets episode 746? I’m curious if it was just a repeat of the last couple year’s catch phrases or if there was anything new beyond the presidential mandate? All the other company’s segments are available to view, but NRXP’s is not. Plus this may be the last episode if I’m not mistaken, maybe one more contracted in May…..?
0 · Reply
dontfeedthebashers
dontfeedthebashers Apr. 27 at 5:04 AM
$NRXP A little project I'm working on. It's a work in progress.
2 · Reply